Baseline assessment before initiating Zepbound should include a comprehensive metabolic panel (which includes electrolytes, kidney and liver function tests), lipid panel, and fasting glucose or HbA1c if clinically indicated
April 11,2025 - Yesterday's CMS announcement that it "does not intend to approve new or extend existing requests" for Designated State Health Programs (DSHP) and Designated State Investment Programs (DSIP) funding could have significant unintended consequences for healthcare delivery and state-led innovations
In summary, despite the challenges posed by tumour heterogeneity, diverse microenvironmental adaptability, and safety concerns, targeted therapies aimed at ROS and related PCD pathways offer new perspectives for precision medicine in breast cancer
In recent studies, BPC-157 has demonstrated promising results in inhibiting tumor growth and exerting anti-cancer effects
This difference fundamentally shapes their efficacy profiles, side effect patterns, and potential clinical applications
